Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,340 | -16,111 | -6,281 | -26,960 | -19,469 |
| Depreciation Amortization | 9 | 6 | 3 | 8 | 6 |
| Accounts payable and accrued liabilities | -2,247 | -1,943 | -1,521 | 1,248 | -64 |
| Other Working Capital | -131 | -1,548 | -2,317 | -599 | -2,020 |
| Other Operating Activity | 9,339 | 8,109 | 3,094 | 5,543 | 5,310 |
| Operating Cash Flow | $-15,370 | $-11,487 | $-7,022 | $-20,760 | $-16,237 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14 | -13 | N/A | -27 | -19 |
| Purchase Of Investment | N/A | N/A | N/A | -4,700 | -2,700 |
| Investing Cash Flow | $-14 | $-13 | $N/A | $-4,727 | $-2,719 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -1,475 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-1,475 | $N/A | $N/A | $N/A | $N/A |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -54 |
| Beginning Cash Position | 111,000 | 111,000 | 111,000 | 136,487 | 136,487 |
| End Cash Position | 94,141 | 99,500 | 103,978 | 111,000 | 117,477 |
| Net Cash Flow | $-16,859 | $-11,500 | $-7,022 | $-25,487 | $-19,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,370 | -11,487 | -7,022 | -20,760 | -16,237 |
| Capital Expenditure | -14 | -13 | N/A | -27 | -19 |
| Free Cash Flow | -15,384 | -11,500 | -7,022 | -20,787 | -16,256 |